A Prospective Multicenter Single-Arm Staged Study to Evaluate the Plan Title: Safety and Effectiveness of EmbraceTM Hydrogel Embolic For Transcatheter Embolization of Arterial Bleeding in Solid Organs and Peripheral Arteries
Brief description of study
This is a prospective, multicenter, single arm, staged clinical study. The study is designed to assess the safety and effectiveness of Embrace Hydrogel Embolic System when used for transarterial embolization for the treatment of arterial bleeding in solid organs and the peripheral vasculature, documented on suitable radiographic and/or endoscopic imaging performed during the index hospitalization. A minimum of 118 subjects will be treated with the Embrace Hydrogel in this study.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Medical Research
-
Age: - 99 Years
-
Gender: All
Updated on
12 Mar 2024.
Study ID: 853330
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
